Company Analysis

Coya Therapeutics, Inc. (COYA)

Nasdaq: COYA · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2021
Grade5.5
◀ Past 4.4● Present 4.6▶ Future 6.9
1 est.

Filings

164 filings since 2017 beside 68 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed May 13, 2026.

Filings a yearinsider forms included
13451614342
202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Aug 7, 2026.SEC letters: 10 in the last 36 months, the newest Mar 19, 2026.
Insider forms 68

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 10-Q Quarterly report Sep 30, 2026
Nov 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 14, 2026 8-K item 8.01 Other event · Current report
Oct 5, 2026 8-K item 8.01 Other event · Current report
Sep 15, 2026 8-K item 8.01 Other event · Current report
Aug 11, 2026 10-Q Quarterly report Jun 30, 2026
Aug 11, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 7, 2026 8-K/A item 5.02 Officer or director change · Current report, amended Mar 29, 2026
Jul 27, 2026 SCHEDULE 13G/A Large holder update, amended
Jun 25, 2026 8-K item 5.07 Shareholder vote · Current report
May 13, 2026 ARS Annual report to shareholders Dec 31, 2025
May 13, 2026 DEFA14A Extra proxy material
May 13, 2026 DEF 14A Proxy statement Jun 25, 2026
May 12, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
May 12, 2026 424B5 Shelf offering
May 12, 2026 10-Q Quarterly report Mar 31, 2026
May 12, 2026 8-K items 2.02, 8.01, 9.01 Results released; Other event · Current report
Apr 2, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Mar 29, 2026
Mar 20, 2026 EFFECT Registration effective
Mar 20, 2026 424B3 Shelf offering
Mar 19, 2026 CORRESP Reply to the SEC
Mar 19, 2026 UPLOAD SEC comment letter
Mar 16, 2026 S-3 Shelf registration
Mar 16, 2026 10-K Annual report Dec 31, 2025
Mar 16, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 12, 2026 SCHEDULE 13G Large holder notice
Jan 30, 2026 8-K items 1.01, 3.02, 7.01, 8.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD); Other event · Current report Jan 29, 2026
Jan 30, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 28, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 20, 2026 8-K item 8.01 Other event · Current report
Jan 8, 2026 8-K item 8.01 Other event · Current report
Dec 17, 2025 8-K item 8.01 Other event · Current report Dec 16, 2025
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Nov 12, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 27, 2025 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Oct 23, 2025
Oct 27, 2025 424B5 Shelf offering
Oct 23, 2025 424B5 Shelf offering
Sep 2, 2025 8-K item 8.01 Other event · Current report Aug 29, 2025
Aug 19, 2025 EFFECT Registration effective
Aug 19, 2025 424B7 Resale prospectus supplement
40 of 164 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton COYA · research, not advice